SCHEMBL6010084

SCHEMBL6010084

O=C(O)OC1Cc2c([nH]c3ccccc23)CN1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.59
CYP1A2 P05177 2/20 0.59
CYP2D6 P10635 2/20 0.59
CYP2C9 P11712 2/20 0.59
CYP2C19 P33261 2/20 0.59
HSD17B10 Q99714 2/20 0.59
ALDH1A1 P00352 1/20 0.59
GAA P10253 1/20 0.59
MAPT P10636 1/20 0.59
HPGD P15428 1/20 0.59
ALOX15 P16050 1/20 0.59
MAPK1 P28482 1/20 0.54
TRPM8 Q7Z2W7 1/20 0.47
CYP19A1 P11511 2/20 0.44
SSTR3 P32745 1/20 0.44
KCNH2 Q12809 1/20 0.44
NR2E1 Q9Y466 2/20 0.43
HTR5A P47898 1/20 0.43
NISCH Q9Y2I1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835931 0.82 KDM4E (0.66) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
Cyclomethyltryptophan SCHEMBL29535380 0.78 KDM4E (0.71) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
Cyclomethyltryptophan SCHEMBL7889282 0.78 KDM4E (0.71) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
Cyclomethyltryptophan SCHEMBL416557 0.78 KDM4E (0.71) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
Cyclomethyltryptophan SCHEMBL416558 0.78 KDM4E (0.71) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6609244 0.78 NR2E1 (0.57) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
Cyclomethyltryptophan SCHEMBL10642614 0.77 KDM4E (0.69) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
Cyclomethyltryptophan SCHEMBL28419799 0.77 KDM4E (0.69) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7525817 0.75 KDM4E (0.62) KDM4ECYP2D6CYP2C19HSD17B10ALDH1A1
SCHEMBL7519979 0.75 CYP2D6 (0.67) KDM4ECYP2D6CYP2C19HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891187-B1 USE OF DERIVATIVES OF TETRAHYDRO-BETA-CARBOLINES AS ANTIMETASTATIC AGENTS HOFFMANN LA ROCHE (CH) 2002-01-30 EP claimed
EP-0736039-B1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK AS (DK) 2000-10-25 EP claimed
EP-2086993-B1 MICHAEL SYSTEMS AS TRANSGLUTAMINASE INHIBITORS ZEDIRA GMBH (DE) 2015-03-11 EP disclosed
EP-0861236-B2 CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS SANOFI AVENTIS DEUTSCHLAND (DE) 2006-08-16 EP disclosed
EP-0703786-B1 USE OF NONA- AND DECAPEPTIDES IN THE PREPARATION OF A DRUG FOR THE TREATMENT OF AIDS ZENTARIS AG (DE) 2002-02-13 EP disclosed
EP-0861236-B1 CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS HOECHST AG (DE) 2002-02-13 EP disclosed
EP-0446706-A2 Peptides with tachykinin-agonistic or -antagonistic activity MERCK PATENT GmbH (DE) 1991-09-18 EP disclosed
EP-0116842-A2 Amino-acids derivatives, process for their preparation and their use BOEHRINGER INGELHEIM KG (DE) 1984-08-29 EP disclosed